Lepidext

Private

Lexington, KentuckyHealthcare & Life Scienceshttps://www.lepidext.com/

Last Round

Series A

Oct 1, 2025

Total Funding Raised

$722,635

Company Overview

Lepidext is an agricultural chemicals company that has developed a biological, active ingredient to control one of the most damaging agricultural pests of corn, cotton, soybeans and many other important crops.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

biological pest controlbioinsecticidepest sterilizationagtechagricultural biotechnologyinsect resistance managementviral bioinsecticidebiocontrolag biotechcorn earworm controlnon-GMO biopesticidecrop protectionsustainable agricultureB2B agricultureUSDA SBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lepidext Comps

Public and private peers based on sector, stage, and business model.

Lepidext comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lepidext Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 1, 2025
Grant	Apr 25, 2023
Grant	Jan 1, 2023
Accelerator	Jan 3, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Angelika Fath-Goodin

Co-Founder And COO

Founding Team

Bruce Webb

Chief Executive Officer

Executive Team

Lepidext Investors

Notable investors and investment history

Lepidext investors
Investor	Rounds
Kentucky Cabinet for Economic Development	Grant
Ag Ventures Alliance	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 5, 2025
Grew 50% QoQ from 6 to 9 employees.
Apr 14, 2025
Grew 50% QoQ from 6 to 9 employees.

View all signals

Lepidext Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Lepidext Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lepidext's valuation, stock price, and market status.

Firmographic Details

HeadquartersLexington, Kentucky

Employee Range10

Year Founded2015

Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.